We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Go Ahead to Eli Lilly’s Alzheimer’s Diagnostic Amyvid
FDA Gives Go Ahead to Eli Lilly’s Alzheimer’s Diagnostic Amyvid
April 13, 2012
The FDA approved Eli Lilly’s radioactive diagnostic for detection of the tell-tale sign of Alzheimer’s disease, setting the stage for its pairing with experimental treatments for the condition now in late-stage development.